Evidence map›Paper›PMID 40542897›Full record

SynthesisEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Treatment package time (TPT) and surgery to post-operative radiotherapy (S-PORT) interval in head and neck cancers: A systematic review and meta-analysis.

Mario Sánchez-Canteli, Juana M García-Pedrero, Juan P Rodrigo

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Mario Sánchez-CanteliDepartment of Otolaryngology, Hospital Universitario de San Agustín (Avilés) and Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain. mariosanchezcanteli@gmail.com.ORCID http://orcid.org/0000-0003-0343-0041
Juana M García-PedreroCiber de Cáncer, CIBERONC, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0002-5891-9488
Juan P RodrigoCiber de Cáncer, CIBERONC, 28029, Madrid, Spain.ORCID http://orcid.org/0000-0003-3063-0890

Funding

Instituto de Salud Carlos III FI23/00037
6 · The paper itself

Abstract

backgroundThe impact of key treatment intervals on head and neck squamous cell carcinoma (HNSCC) survival remains unclear.

methodsThis systematic review and meta-analysis, conducted following PRISMA guidelines, assessed 22 cohort studies including 322,569 patients. The mean threshold for prolonged total treatment package time (TPT) was 95.21 days, while for surgery-to-postoperative radiotherapy (S-PORT), it was 6.9 weeks.

resultsBoth prolonged TPT and S-PORT intervals were significantly associated with reduced survival (TPT: HR = 1.25; S-PORT: HR = 1.03; p < 0.0001). However, the negative impact of extended TPT was more pronounced compared to S-PORT delays.

conclusionThese findings suggest that minimizing TPT delays is critical for optimizing HNSCC outcomes. However, substantial heterogeneity across studies limits the generalizability of results. Further research is needed to establish standardized treatment timelines and improve survival rates in HNSCC patients.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckTime-to-TreatmentHumansTime FactorsHead and neck squamous cell carcinomaPrognosisSurgery-to-postoperative radiotherapySurvival outcomesTotal treatment package time

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.